COVID-19 vaccine acceptance in the general population and under-resourced communities from high-income countries: realist review
- PMID: 38631831
- PMCID: PMC11029206
- DOI: 10.1136/bmjopen-2024-084560
COVID-19 vaccine acceptance in the general population and under-resourced communities from high-income countries: realist review
Abstract
Objective: To compare vaccination willingness before rollout and 1 year post-rollout uptake among the general population and under-resourced communities in high-income countries.
Design: A realist review.
Data sources: Embase, PubMed, Dimensions ai and Google Scholar.
Setting: High-income countries.
Definitions: We defined vaccination willingness as the proportion of participants willing or intending to receive vaccines prior to availability. We defined vaccine uptake as the real proportion of the population with complete vaccination as reported by each country until November 2021.
Results: We included data from 62 studies and 18 high-income countries. For studies conducted among general populations, the proportion of vaccination willingness was 67% (95% CI 62% to 72%). In real-world settings, the overall proportion of vaccine uptake among those countries was 73% (95% CI 69% to 76%). 17 studies reported pre-rollout willingness for under-resourced communities. The summary proportion of vaccination willingness from studies reporting results among people from under-resourced communities was 52% (95% CI 0.46% to 0.57%). Real-world evidence about vaccine uptake after rollout among under-resourced communities was limited.
Conclusion: Our review emphasises the importance of realist reviews for assessing vaccine acceptance. Limited real-world evidence about vaccine uptake among under-resourced communities in high-income countries is a call to context-specific actions and reporting.
Keywords: COVID-19; Meta-Analysis; Vaccination.
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures


Similar articles
-
Interventions to increase COVID-19 vaccine uptake: a scoping review.Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD015270. doi: 10.1002/14651858.CD015270. Cochrane Database Syst Rev. 2022. PMID: 35920693 Free PMC article.
-
The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake.PLoS One. 2023 Nov 2;18(11):e0293184. doi: 10.1371/journal.pone.0293184. eCollection 2023. PLoS One. 2023. PMID: 37917650 Free PMC article.
-
Willingness to take COVID-19 vaccination in low-income countries: Evidence from Ethiopia.PLoS One. 2022 Mar 3;17(3):e0264633. doi: 10.1371/journal.pone.0264633. eCollection 2022. PLoS One. 2022. PMID: 35239711 Free PMC article.
-
Factors Influencing COVID-19 Vaccine Acceptance in High Income Countries Prior to Vaccine Approval and Rollout: A Narrative Review.Int J Public Health. 2022 Feb 16;67:1604221. doi: 10.3389/ijph.2022.1604221. eCollection 2022. Int J Public Health. 2022. PMID: 35250430 Free PMC article. Review.
-
The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries.Front Public Health. 2023 Jan 12;10:1087138. doi: 10.3389/fpubh.2022.1087138. eCollection 2022. Front Public Health. 2023. PMID: 36711400 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous